Rights and permissions
About this article
Cite this article
Vernakalant a viable option for preventing AF recurrence. Inpharma Wkly. 1630, 7 (2008). https://doi.org/10.2165/00128413-200816300-00019
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200816300-00019